
In this enlightening episode, Dr. Kevin Korenblat from Washington University in St. Louis explores the intricacies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
Click here to access his list of active clinical trials: http://resfyh.com/SP0121
Click here to sign up for his monthly SMS-based study updates: http://resfyh.com/SI0121
Gain valuable insights into the latest research, effective treatment options, and practical prevention strategies. Dr. Korenblat also highlights the benefits of participating in clinical trials, offering listeners a chance to learn how these trials can provide access to cutting-edge treatments and contribute to groundbreaking medical advancements. Tune in to stay informed and take control of your liver health.